The Milton and Carroll Petrie Department of Urology is part of the Mount Sinai Health System and has been a leader in clinical practice, research, and education since 1852, with the establishment of The Mount Sinai Hospital. Today, depth of knowledge, breadth of experience, and compassion for patients continue to characterize our highly respected team of board certified and fellowship trained physicians whom are also faculty of the Icahn School of Medicine at Mount Sinai. Our dedicated team of urologists specialize in treatment of urologic cancer, kidney stones, sexual dysfunction, and endourological conditions. Our surgeons and scientists have pioneered the adoption of novel diagnostic techniques and minimally invasive treatments for prostate, kidney, bladder, and renal cell cancers though our industry-leading international symposia.
As globally recognized experts, we provide in depth training on cutting-edge medical advances and are among the most renowned in the world performing robotic surgery making our robotics program among the most robust in the country. Our Kidney Stone Center was the first of its kind in New York, focusing on both treatment and prevention. Genomic testing and advanced imaging are routine for patients with prostate cancer in order to provide them with the most personalized and precise treatment protocols. Our specialized men’s, women’s, children’s, reconstructive, and gender affirming programs ensure that we can meet the needs of every patient with exceptional quality of service.
The Department of Urology at The Mount Sinai Hospital is ranked No. 11 in the nation by U.S. News & World Report® for 2024-25.
The Milton and Carroll Petrie Department of Urology is part of the Mount Sinai Health System and has been a leader in clinical practice, research, and education since 1852, with the establishment of The Mount Sinai Hospital. Today, depth of knowledge, breadth of experience, and compassion for patients continue to characterize our highly respected team of board certified and fellowship trained physicians whom are also faculty of the Icahn School of Medicine at Mount Sinai. Our dedicated team of urologists specialize in treatment of urologic cancer, kidney stones, sexual dysfunction, and endourological conditions. Our surgeons and scientists have pioneered the adoption of novel diagnostic techniques and minimally invasive treatments for prostate, kidney, bladder, and renal cell cancers though our industry-leading international symposia.
As globally recognized experts, we provide in depth training on cutting-edge medical advances and are among the most renowned in the world performing robotic surgery making our robotics program among the most robust in the country. Our Kidney Stone Center was the first of its kind in New York, focusing on both treatment and prevention. Genomic testing and advanced imaging are routine for patients with prostate cancer in order to provide them with the most personalized and precise treatment protocols. Our specialized men’s, women’s, children’s, reconstructive, and gender affirming programs ensure that we can meet the needs of every patient with exceptional quality of service.
The Department of Urology at The Mount Sinai Hospital is ranked No. 11 in the nation by U.S. News & World Report® for 2024-25.
Latest Content |view more
Significant Advances in Cancer Treatment and Research for the Department of Urology
Significant advances in patient care and research by the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai were recognized as the Department recorded a number of significant milestones in 2023 ...
An Important Milestone: Marking the 500th Robotic Cystectomy Surgery in the Bladder Cancer Program
A team at the Department of Urology recently performed the 500throbotic cystectomy in Mount Sinai’s Bladder Cancer Program, a significant milestone that underscores innovations in patient care, research, and clinical excellence that make ...
Secure Your Spot at the annual Mount Sinai Urology Robotics Symposium at AUA2025
Date: Saturday, April 26 Time: 5:00pm Location: The Venetian Convention & Expo Center, Las Vegas
The Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai has long been a leader in clinical practice, education, and research, where we perform complex procedures using robotics, laparoscopy, and ...
Researchers Develop New AI Tool That Could Reshape Prostate Cancer Care
Researchers at the Icahn School of Medicine at Mount Sinai have developed an advanced artificial intelligence (AI)-driven tool to improve the management and prognosis of prostate cancer.
Focal Therapy: Treating Prostate Cancer Without the Troubling Side Effects
The emerging technique of focal therapy, made possible by advances in imaging and precision biopsies, offers a critical bridge between active surveillance and more radical therapy for men who clinically qualify for the option.
As the number of patients presenting for feminizing genital surgery continues to grow, there is limited comparative data on the different approaches to help inform patient decisions on the best option for them. Mount Sinai surgeon Rajveer ...
PCNL Surgery to Remove Large Kidney Stones Has a Novel Tubeless Look at Mount Sinai
The Department or Urology has worked diligently over the years to bring percutaneous nephrolithotomy (PCNL) to its latest threshold: a totally tubeless outpatient procedure performed with the help of ultrasound guidance and improved patient positioning.
Working to Ensure a Healthful Sexual Life for Male Patients After Prostate Surgery
Penile rehabilitation following prostatectomy and radiation therapy to restore erectile function to pre-operative levels has become a priority for the Men’s Health Program at The Mount Sinai Hospital.
Faced with a growing number of patients who are presenting with benign prostatic hyperplasia (BPH) due to an aging population, Mount Sinai researchers are leading the effort to assess and validate new technologies to gain more insights ...
In the quest to achieve improved outcomes among patients who present with muscle-invasive bladder cancer, Mount Sinai researchers are looking beyond conventional radiographic tools to the potential of circulating tumor DNA (ctDNA) assays ...
For a patient presenting with upper tract urothelial carcinoma (UTUC) involving a horseshoe kidney, Mount Sinai surgeon Ketan K. Badani, MD, FRCS (Hon.), achieved positive outcomes through a minimally invasive robot-assisted approach that ...
A New Approach for Robot-Assisted Partial Nephrectomy Offers Several Benefits
For more than two decades, Mount Sinai surgeon Ketan K. Badani, MD, FRCS (Hon.) has consistently pushed the boundaries of robot-assisted partial nephrectomy, first using multiport systems and more recently single-port technology. Now, ...
Mount Sinai is pioneering an innovative technique for performing radical cystectomy by using a single-port robotic approach that would expand the pool of patients to include those previously excluded because of prior procedures that left ...
Balancing effective prostate cancer treatment with preservation of urinary and sexual functions has long proven challenging for many urology surgeons. A new Mount Sinai study confirms that a novel approach to prostatectomy is safe and ...
The Mount Sinai Robert F. Smith Mobile Prostate Screening Unit is living up to its vast promise. Launched in 2022, it has logged some 15,000 miles across 539 community screening events and sites, screening more than 9,000 people. And its ...
The Sixth International Prostate Cancer and World Congress of Urologic Oncology attracted about 1,000 registrants and more than 800 attendees, featuring more than 100 distinguished faculty members from around the globe and representing ...
AI-powered planning and robotic precision revolutionize treatment, preserving continence and sexual function
Rethinking the Role of Lymph Nodes in Prostate Cancer: A study from Mount Sinai
In this study, Ash Tewari, MD and additional authors at Mount Sinai suggest re-evaluating the common practice of removing lymph nodes during prostate cancer surgery, as it can be risky and may not provide therapeutic benefits.
A recent study conducted at Mount Sinai Hospital has demonstrated the safety and effectiveness of the Menon Precision Prostatectomy (MPP), a surgical technique for treating prostate cancer while preserving urinary and sexual functions.
One of the biggest challenges in managing aggressive and locally advanced prostate cancer is how best to balance the competing goals of achieving cancer control with maintaining continence and sexual function among patients.
The Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai has long been a leader in clinical practice, education, and research, where we perform complex procedures using robotics, laparoscopy, and ...
Landmark Symposium on Urologic Oncology Showcases Groundbreaking Research and Clinical Practices
The Icahn School of Medicine at Mount Sinai recently took center stage in the global medical community by hosting the Fifth International Prostate Cancer Symposium and World Congress of Urologic Oncology.
New Algorithm Guides Decision-Making for Single-Port and Multiport Robotic Nephrectomy
A patient-focused, clinical decision-making algorithm to determine the optimal approach between single-port and multiport robotic surgery will help guide surgeons in selecting the appropriate treatment for each patient.
Ureteroscopies Without Wires and Stents Could Be the Field’s Next Gold Standard
Mantu Gupta, MD, is leading the movement to set a new gold standard for the field through the use of flexible ureteroscopes untethered to wires, sheaths, and stents—and the severe discomfort they can cause patients.
In this video, Dr. Badani, Director of the Kidney Cancer Center at the Mount Sinai Health System, and Professor of Urology at the Icahn School of Medicine at Mount Sinai, demonstrates this standardized approach that has evolved over his large experience.
Continuing Innovation Leads to Advances in Treatments for BPH Patients
While Aquablation® continues to gain traction as a highly effective therapy for benign prostatic hyperplasia (BPH), the Optilume® BPH Catheter System, another innovative treatment option using drug-coated balloon technology moved closer ...
A Mount Sinai Team of Urologic Researchers Advances a Unique Model of Bladder Cancer Resistance
An inactivated form of tuberculosis bacterium known as Bacillus Calmette-Guerin (BCG) has been the only first-line therapy for urologists treating non-muscle invasive bladder cancer.
In its second year, the Mount Sinai Robert F. Smith Mobile Prostate Cancer Screening Unit is demonstrating its ability to change the outcome of prostate cancer for the communities Mount Sinai serves, even as the Department continues to ...
The Urology Residency Program at Mount Sinai: A Focus on Continuous Improvement
A key focus for leaders of the Department of Urology Training Program, and one reason for its success, is a commitment to continuous improvement, and a critical element of that has been keeping lines of communication open.
Probing “DNA Damage Repair Genes” to Change Outcomes for Castration-Resistant Prostate Cancer
Prostate cancer is the second leading cause of cancer death among men in the United States. For patients whose disease do not respond well to treatment, a Mount Sinai researcher is attempting to change that reality with his work on BRCA2 ...
Register Now for the Mount Sinai Urology Symposium Dec 8-10 in NYC
Join us for the Fifth International Prostate Cancer Symposium and World Congress of Urologic Oncology presented by Mount Sinai.
New Urologic Oncology Fellowship Program Aims for Research, Surgical Excellence
The new urologic oncology program launched by the Department of Urology, fully accredited by the Society of Urologic Oncology, has an equal focus on developing clinical and research skills.
While many bladder cancer patients have benefited from neoadjuvants, their application in prostate and kidney cancers is currently confined to clinical trials.
Transgender Surgery at the Department of Urology at Mount Sinai with Miroslav Djordjevic MD, PhD
Dr. Djordjevic of the Mount Sinai Department of Urology's transgender surgery program discusses a variety of feminizing genital surgery options for vaginoplasty and techniques for masculinizing genital surgery.
Transgender Surgery at the Department of Urology at Mount Sinai with Rajveer Purohit, MD, MPH
Dr. Purohit of the Mount Sinai Department of Urology's transgender surgery program shares feminizing genital surgery options for vaginoplasty, metoidioplasty and phalloplasty.
Case Study: Multidisciplinary Care for Renal Replacement Patient
A neonate with severe kidney injury and likely urinary blockage causing severe hydronephrosis received successful treatment at Mount Sinai for his rare birth defect.
Mount Sinai has developed a protocol that eliminates opioids from postoperative pain management with exceptional results.
Two Physician-Researchers Making Unique Contributions to Urology Innovation
Two physician-researchers in the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai have been recognized for making unique contributions to urology research...
Harnessing Immunotherapy to Achieve Improved Outcomes for Patients With Prostate Cancer
Although there is considerable interest in using immunotherapy to combat and control prostate cancer, there has been little progress made in harnessing the potential of this approach.
Organoids Enable Pathophysiology, Treatment Studies of Rare Renal Cell Carcinomas
For years, rare renal cell carcinomas (RCCs), such as papillary RCC, have been understudied because their incidences are too low to support clinical trials.
Better Diagnosis Holds the Key to Improved Outcomes for BPH Patients
As the family of technologies for treating benign prostatic hyperplasia (BPH) continues to grow, the key to successful outcomes for male patients may well rest on a rather simple tenet: better diagnostic acumen.
Mount Sinai’s Department of Urology continues to make strides in training a new generation in the necessary clinical, surgical, and decision-making skills to deliver outstanding care to patients in an area undergoing rapid change.
Advancing the Field of Gender Affirming Surgery Through Innovative Approaches
Mount Sinai has established itself as a leader in gender affirming surgery and reconstruction of genitalia, thanks in part to the pioneering work of Miroslav Djordjevic, MD, PhD, a leading authority on surgery for transgender individuals.
Prostate Cancer Program: Two Pioneering Studies
For more than a decade, Ash Tewari, MBBS, MCh, FRCS (Hon.), has been a leader in advancing the safety and precision of robot-assisted radical prostatectomies.
By continuing to perfect the miniaturization of percutaneous nephrolithotomy (PCNL), surgeons at the Mount Sinai Department of Urology are significantly improving outcomes for patients with larger kidney stones.
Kidney Research Pipeline to Enhance Precision in Surgical Intervention Decisions
Advances in imaging, biomarkers, and genetic testing continue to benefit patients who present with prostate and bladder cancers.
Urology Training Program at Mount Sinai Offers Residents Unique Opportunities
The Urology Residency Program of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai provides residents the opportunity to train in all aspects of the medical and surgical evaluation and treatment ...
An innovative effort by the Milton and Carroll Petrie Department of Urology and Ash Tewari, MBBS, MCh, FRCS (Hon.), Professor and System Chair, to improve early detection of prostate cancer among at-risk populations in New York City...
Message from the Chair: Milestones are meant to be celebrated and surpassed. For the year 2022, our milestones are a reflection of our collective efforts to save lives—through innovative patient care and groundbreaking research and scholastic activities.
Immunotherapy After Bladder Cancer Surgery Shows Excellent Cancer-free Survival Rates
Immunotherapy after surgery helped reduce cancer recurrence in patients with urothelial cancer of the bladder or other sites in the urinary tract that had invaded the muscle...
Mount Sinai Pediatric Stone Clinic Diagnoses, Treats, and Prevents Kidney Stones in Children
The Mount Sinai Pediatric Stone Clinic is a comprehensive, interdisciplinary program focused on the diagnosis, management, and prevention of kidney stones in children.
The COVID-19 pandemic forced us to find the strength we never knew we had. It has revealed our anti-fragile mindset in our mission to provide unparalleled, comprehensive, and innovative patient care.
Ash Tewari, MD presents insights into the role of genomics on prostate cancer
A Conversation With Deepak Chopra
Ash Tewari, MBBS, MCh, FRCS (Hon.) discusses wellness and well-being with Deepak Chopra, MD
Urology Training Program at Mount Sinai Prepares Residents for Success
Learn more about the Urology Residency Program of the Department of Urology at the Icahn School of Medicine at Mount Sinai
Ultra-Mini PCNL: A New Approach to Treating Kidney Stones
At Mount Sinai, Mantu Gupta, MD, a pioneer in PCNL procedures, is helping to popularize a new approach to treating kidney stones that is not only cost efficient but also safe and effective: ultra-mini PCNL
Offering Patients Innovative Options for Penile Enhancement
For years, Robert Valenzuela, MD, cautioned patients that they might experience shortening of their penis following a penile prosthesis implantation (PPI) for erectile dysfunction. Today, he advises them that they might have a longer one
Developing a Single Port Donor Nephrectomy Program to Provide Benefits for Patients
Michael Palese, MD continues to advance the standard of care for patients undergoing robotic multiport living donor nephrectomy (LDN)
Ketan Badani, MD believes a significant percentage of kidney and adrenal tumors can be done using a robot-assisted retroperitoneal approach